Dhpstm2d(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Dhpstm2d(EUCOMM)Wtsi |
Name: |
deoxyhypusine synthase; targeted mutation 2d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5812111 |
Synonyms: |
Dhs- |
Gene: |
Dhps Location: Chr8:85798386-85801791 bp, + strand Genetic Position: Chr8, 41.55 cM
|
Alliance: |
Dhpstm2d(EUCOMM)Wtsi page
|
IMPC: |
Dhps gene page |
|
Mutant Cell Lines: |
EPD0628_1_B06, EPD0628_1_C06, EPD0628_1_F05 |
Germline Transmission: |
Earliest citation of germline transmission:
J:236582
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 85798794 of Chromosome 8 upstream of exon 2 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of exon 7 at position 85801230. Exons 2-7 are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked exons 2-7.
(J:236582)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Dhps Mutation: |
21 strains or lines available
|
|
Original: |
J:236582 Pallmann N, et al., Biological Relevance and Therapeutic Potential of the Hypusine Modification System. J Biol Chem. 2015 Jul 24;290(30):18343-60 |
All: |
1 reference(s) |
|